1
|
Oteri V, Piane S, Cocci E. The use of telecytology for the evaluation of thyroid nodules fine-needle aspiration biopsy specimens: a systematic review. J Endocrinol Invest 2024:10.1007/s40618-024-02378-3. [PMID: 38704449 DOI: 10.1007/s40618-024-02378-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/01/2023] [Accepted: 04/18/2024] [Indexed: 05/06/2024]
Abstract
PURPOSE Fine needle aspiration biopsy (FNAB) is currently the gold standard for diagnosis and treatment of thyroid nodules, but the growing need for anatomic pathology services in small communities is becoming a challenge. Telecytology (TC) is defined as the electronic transmission of cytological digital images, and allows for the collection of samples, primary diagnosis, and other applications without the physical presence of a pathologist. Our aim is to systematically report, summarize, and critically analyze the most up to date applications of TC to thyroid nodules FNAB evaluation. METHODS We performed a systematic literature review by searching PubMed, Embase, and Cochrane Library databases. Only studies published in peer-reviewed scientific journals were included. Data were extracted using the PICO framework and critically analyzed. PRISMA guidelines were applied, and the risk of bias in the included studies was assessed using the ROBINS-I tools. The methodological quality was assessed following GRADE criteria. RESULTS We included 13 observational studies, resulting in a total of 3856 evaluated FNAB specimens. The majority of studies (63.6%) showed an excellent concordance rate of diagnosis via TC and conventional cytology. TC can be used to perform preliminary assessment of samples with a concordance rate ranging from 74 and 100%, showing a significant reduction of the non-diagnostic rate. Image quality was referred to as perfect or nearly perfect in most cases, regardless of telecytology technique. CONCLUSION Telecytology could be a valuable implementation for thyroid FNAB evaluation both for primary diagnosis and preliminary assessment of samples.
Collapse
Affiliation(s)
- V Oteri
- Endocrine Unit, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Hospital, Catania, Italy.
| | - S Piane
- Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
| | - E Cocci
- Department of Clinical and Experimental Medicine, Marche Polytechnic University, Ancona, Italy
| |
Collapse
|
2
|
Chen-Yost HI, Bammert C, Hao W, Heymann JJ, Lin DM, Marotti J, Waraksa-Deutsch T, Huang M, Krishnamurti U, Lin O, Ly A, Moatamed N, Pantanowitz L, Roy-Chowdhuri S. Changing digital and telecytology practices post COVID-19 comparing ASC survey results from 2016 to 2023. J Am Soc Cytopathol 2024; 13:194-204. [PMID: 38582697 DOI: 10.1016/j.jasc.2024.02.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2023] [Revised: 02/07/2024] [Accepted: 02/10/2024] [Indexed: 04/08/2024]
Abstract
INTRODUCTION During the COVID-19 pandemic, the need for digital pathology tools became more urgent. However, there needs to be more knowledge of the use in cytology. We aimed to evaluate current digital cytology practices and attitudes and compare the results with a pre-COVID-19 American Society of Cytopathology (ASC) survey. MATERIALS AND METHODS Fourteen survey questions assessing current attitudes toward digital cytology were developed from a 2016 ASC Digital Pathology Survey. Ten new survey questions were also created to evaluate telecytology use. The survey was e-mailed to ASC members over 6 weeks in 2023. RESULTS A total of 123 individuals responded (116 in 2016). Attitudes toward digital cytology were unchanged; most participants stated digital cytology is beneficial (87% 2023 versus 90% 2016). The percentage of individuals using digital cytology was unchanged (56% in 2016 and 2023). However, telecytology for rapid onsite assessment (ROSE) is now considered the best application (55% 2023 versus 31% 2016). Forty-three institutions reported using digital and telecytology tools; 40% made implementations after 2020; most did not feel that COVID-19 affected digital cytology (56%). Telecytology for ROSE is the most common application now (78%) compared with education (30%) in 2016. Limitations for implementing digital imaging in cytology included inability to focus (38%) and expense (33%). CONCLUSIONS General attitudes toward digital tools by the cytology community have essentially remained the same between 2016 and now. However, telecytology for ROSE is increasingly being used, which supports a need for validation and competency guidelines.
Collapse
Affiliation(s)
| | - Catherine Bammert
- School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Wei Hao
- Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan
| | - Jonas J Heymann
- Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medicine, New York, New York
| | - Diana Murro Lin
- Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama
| | - Jonathan Marotti
- Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire
| | | | - Min Huang
- Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania
| | - Uma Krishnamurti
- Department of Pathology, Yale School of Medicine, New Haven, Connecticut
| | - Oscar Lin
- Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Amy Ly
- Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts
| | - Neda Moatamed
- Department of Pathology and Laboratory Medicine, University of California at Los Angeles, Los Angeles, California
| | - Liron Pantanowitz
- Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
| | - Sinchita Roy-Chowdhuri
- Department of Pathology and Laboratory Medicine, MD Anderson Cancer Center, Houston, Texas
| |
Collapse
|
3
|
Miguel R, Gregorio B, Santos C, Andriotti C, Valle L, Saieg M. Validation of cytopathology specimens for digital pathology. Cytopathology 2023; 34:302-307. [PMID: 36974500 DOI: 10.1111/cyt.13234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2022] [Revised: 03/02/2023] [Accepted: 03/05/2023] [Indexed: 03/29/2023]
Abstract
INTRODUCTION Digital cytopathology is being progressively implemented in centres worldwide, but impediments such as the three-dimensionality of specimens and the size of scanned images have prevented its use from becoming widespread. This study aimed to validate the use of digital whole slide image scanning of cytopathology samples for routine sign-out. METHODS Specimens were scanned using the Leica Aperio GT 450 System. The following sample types were used: liquid-based cytology, direct conventional smears from fine needle aspirates and cytospins. Cases were validated by the same pathologist who originally rendered the conventional diagnosis, with a washout of at least 3 months. Final digital diagnoses were compared to the original analogical diagnoses, and cases were considered concordant up to a one-degree difference between the original and digital diagnoses. Reasons for the unsuccessful scanning of slides were also noted. The technical procedures followed the College of American Pathologists' guidelines for digital pathology validation. RESULTS A total of 730 slides from 383 cases (337 female, 51 male; median age 42) were successfully scanned. These cases consisted of the following sample types: 81 (21.1%) conventional smears, 240 (62.7%) liquid-based cytology samples and 62 (16.2%) cytospins. There were only five discordant cases, with a 98.7% agreement between original and digital diagnoses using the difference rate of up to one degree. Seventy-seven slides (10.5%) had to be rescanned due to technical problems. The main reasons for unsuccessful scanning were paucicellular samples (44; 57.1%), the thickness of the smears (18; 23.4%) and issues with the coverslip (15; 19.5%). CONCLUSION Cytological specimens can be successfully scanned and used for digital pathology, with excellent agreement with the original diagnoses.
Collapse
Affiliation(s)
| | | | | | | | | | - Mauro Saieg
- Fleury Group, São Paulo, Brazil
- Santa Casa Medical School, São Paulo, Brazil
| |
Collapse
|
4
|
De Las Casas LE, Hicks DG. Pathologists at the Leading Edge of Optimizing the Tumor Tissue Journey for Diagnostic Accuracy and Molecular Testing. Am J Clin Pathol 2021; 155:781-792. [PMID: 33582767 PMCID: PMC8130880 DOI: 10.1093/ajcp/aqaa212] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
OBJECTIVES Tumor biomarker analyses accompanying immuno-oncology therapies are coupled with a tumor tissue journey aiming to guide tissue procurement and allow for accurate diagnosis and delivery of test results. The engagement of pathologists in the tumor tissue journey is essential because they are able to link the preanalytic requirements of this process with pathologic evaluation and clinical information, ultimately influencing treatment decisions for patients with cancer. The aim of this review is to provide suggestions on how cancer diagnosis and the delivery of molecular test results may be optimized, based on the needs and available resources of institutions, by placing the tumor tissue journey under the leadership of pathologists. METHODS Literature searches on PubMed and personal experience provided the necessary material to satisfy the objectives of this review. RESULTS Pathologists are usually involved across many steps of the tumor tissue journey and have the requisite knowledge to ensure its efficiency. CONCLUSIONS The expansion of oncology diagnostic testing emphasizes the need for pathologists to acquire a leadership role in the multidisciplinary effort to optimize the accuracy, completeness, and delivery of diagnoses guiding personalized treatments.
Collapse
Affiliation(s)
| | - David G Hicks
- University of Rochester Medical Center, Rochester, NY, USA
| |
Collapse
|
5
|
Jiang XS, Madrigal E. Innovations: Innovating together while social distancing. Cancer Cytopathol 2020; 129:99-101. [PMID: 33058521 PMCID: PMC7675745 DOI: 10.1002/cncy.22325] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Accepted: 06/16/2020] [Indexed: 11/07/2022]
|
6
|
Delteil C, Haffner A, Fritih R, Bouvier C, Taix S, Macagno N. [Point of view: A lesson from lockdown, histopathology through videoconferencing]. Ann Pathol 2020; 41:4-8. [PMID: 33039153 PMCID: PMC7539803 DOI: 10.1016/j.annpat.2020.09.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2020] [Revised: 08/25/2020] [Accepted: 09/18/2020] [Indexed: 11/29/2022]
Abstract
Le confinement et la distanciation sociale ont généralisé l’usage de la visioconférence, tant dans la sphère privée que professionnelle. Ainsi, l’utilisation de la visioconférence a considérablement augmenté durant la période du confinement et cette technologie a été utilisée dans le service d’anatomie pathologique du centre hospitalo-universitaire Timone, à Marseille, à visée universitaire, hospitalière et de recours. Nous apportons notre point de vue concernant l’utilisation de cet outil informatique. La discussion de lames par visioconférence est un exercice nouveau et particulier ; plusieurs recommandations sont émises pour un bon déroulement de ces réunions d’histopathologie à distance.
Collapse
Affiliation(s)
- Clémence Delteil
- Anatomie pathologique, AP-HM, CHU de Timone, Marseille, France; Institut médico-légal de Marseille, AP-HM, CHU de Timone, 264, rue St-Pierre, 13385 Marseille, France.
| | - Aurélie Haffner
- Anatomie pathologique, AP-HM, CHU de Timone, Marseille, France
| | - Radia Fritih
- Anatomie pathologique, AP-HM, CHU de Timone, Marseille, France
| | - Corinne Bouvier
- Anatomie pathologique, AP-HM, CHU de Timone, Marseille, France; Aix-Marseille Université, Inserm, MMG, Marseille, France
| | - Sébastien Taix
- Biopathologie, institut Paoli-Calmettes, Marseille, France
| | - Nicolas Macagno
- Anatomie pathologique, AP-HM, CHU de Timone, Marseille, France; Aix-Marseille Université, Inserm, MMG, Marseille, France
| |
Collapse
|
7
|
Griffith ML, Bischoff LA, Baum HBA. Approach to the Patient With Thyrotoxicosis Using Telemedicine. J Clin Endocrinol Metab 2020; 105:5856156. [PMID: 32525973 PMCID: PMC7454600 DOI: 10.1210/clinem/dgaa373] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/10/2020] [Revised: 05/30/2020] [Accepted: 06/08/2020] [Indexed: 12/15/2022]
Abstract
CONTEXT The potential for endocrine care via telemedicine has been recognized since the early 2000s when clinical outcome data demonstrated improvements in glycemic control with telemedicine. The widespread use of telemedicine during the COVID-19 pandemic has pushed telemedicine beyond diabetes care and into clinical areas with a paucity of published data. The evaluation and treatment of thyrotoxicosis heavily relies on laboratory assessment and imaging with physical exam playing a role to help differentiate the etiology and assess the severity of thyrotoxicosis. CASE DESCRIPTION We describe a patient presenting for evaluation of new thyrotoxicosis via telemedicine, and describe modifications to consider for thorough, safe evaluation via telemedicine. CONCLUSION Telemedicine may be an ideal way to assess and treat patients with thyrotoxicosis who are not able to physically attend a visit with an endocrinologist but still have access to a laboratory for blood draws. Potential challenges include access to imaging and high-volume surgeons if needed. Clinical and economic outcomes of telemedicine care of thyrotoxicosis should be studied so that standards of care for endocrine telemedicine can be established.
Collapse
Affiliation(s)
- Michelle L Griffith
- Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Lindsay A Bischoff
- Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, Tennessee
| | - Howard B A Baum
- Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, Tennessee
- Correspondence and Reprint Requests: Howard B.A. Baum, MD, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, MCE 8210, 1215 21st Avenue South, Nashville, TN 37232. E-mail:
| |
Collapse
|
8
|
Zafereo M, Yu J, Onakoya PA, Aswani J, Baidoo K, Bogale M, Cairncross L, Cordes S, Daniel A, Diom E, Maurice ME, Mohammed GM, Biadgelign MG, Koné FI, Itiere A, Koch W, Konney A, Kundiona I, Macharia C, Mashamba V, Moore MG, Mugabo RM, Noah P, Omutsani M, Orloff LA, Otiti J, Randolph GW, Sebelik M, Todsen T, Twier K, Fagan JJ. African Head and Neck Society Clinical Practice guidelines for thyroid nodules and cancer in developing countries and limited resource settings. Head Neck 2020; 42:1746-1756. [PMID: 32144948 DOI: 10.1002/hed.26094] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2019] [Revised: 10/11/2019] [Accepted: 01/15/2020] [Indexed: 12/22/2022] Open
Abstract
BACKGROUND International thyroid nodule and cancer management guidelines generally fail to take into account potential limitations in diagnostic and treatment resources. METHODS Thyroid cancer specialists from the African Head and Neck Society and American Head & Neck Society Endocrine Section developed guidelines for diagnosis and management of thyroid nodules and cancer in low resource settings. Recommendations were based on literature review and expert opinion, with level of evidence defined. RESULTS Using the ADAPTE process, diagnostic and treatment algorithms were adapted from the National Comprehensive Cancer Network (NCCN). Low resource settings were simulated by systematically removing elements such as availability of laboratory testing, hormone replacement, imaging, and cytopathology from NCCN guidelines. CONCLUSIONS Successful management of thyroid nodules and cancer in low resource settings requires adaptation of treatment methodologies. These guidelines define specific scenarios where either more or less aggressive intervention for thyroid pathology may be advisable based on limited available resources.
Collapse
Affiliation(s)
- Mark Zafereo
- Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, Texas
| | - Justin Yu
- Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, Texas
| | - Paul A Onakoya
- Department of Otorhinolaryngology, University of Ibadan, Ibadan, Nigeria
| | - Joyce Aswani
- Department of Surgery, College of Health Sciences, University of Nairobi, Nairobi, Kenya
| | - Kenneth Baidoo
- Department of Otolaryngology, Korle Bu Teaching Hospital, Accra, Ghana
| | - Mesele Bogale
- Department of Surgery, Adama Hospital Medical College, Adama, Ethiopia
| | - Lydia Cairncross
- Department of Surgery, Groote Schuur Hospital, Cape Town, South Africa
| | | | - Adekunle Daniel
- Department of Otorhinolaryngology, University of Ibadan, Ibadan, Nigeria
| | - Evelyne Diom
- Department of Otolaryngology, Assane Seck University, Ziguinchor, Senegal
| | - Mpessa E Maurice
- Department of Otolaryngology, University Hospital of Yopougon, Abidjan, Ivory Coast
| | - Garba M Mohammed
- Department of Otolaryngology, Kaduna State University, Kaduna, Nigeria
| | | | - Fatogoma I Koné
- Department of Head and Neck Surgery, Gabriel Touré University Hospital, Bamako, Mali
| | - Arnaud Itiere
- Department of Otorhinolaryngology, General Hospital of Brazzaville, Brazzaville, Congo
| | - Wayne Koch
- Department of ORL/Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland
| | - Anna Konney
- Department of Otolaryngology, Komfo Anokye Teaching Hospital, Kumasi, Ghana
| | - Innocent Kundiona
- Department of Otolaryngology, Parirenyatwa Group of Hospitals, Harare, Zimbabwe
| | - Chege Macharia
- Department of General Surgery, AIC Kijabe Hospital, Kenya
| | - Victor Mashamba
- Department of Otorhinolaryngology, Muhimbili National Hospital, Dar es Salaam, Tanzania
| | - Michael G Moore
- Department of Otolaryngology-Head and Neck Surgery, Indiana University, Indianapolis, Indiana
| | - Rajab M Mugabo
- Department of Otolaryngology, King Faisal Hospital, Kigali, Rwanda
| | - Patrick Noah
- Department of Surgery, University of Malawi, Zomba, Malawi
| | - Mary Omutsani
- Department of Otolaryngology-Head and Neck Surgery, Kenyatta National Hospital, Nairobi, Kenya
| | - Lisa A Orloff
- Department of Otolaryngology, Division of Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California
| | - Jeffrey Otiti
- Department of Otolaryngology, Uganda Cancer Institute, Kampala, Uganda
| | - Gregory W Randolph
- Division of Thyroid and Parathyroid Surgery, Department of Otolaryngology, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston, Massachusetts
| | - Merry Sebelik
- Department of Otolaryngology, Head and Neck Surgery, Emory School of Medicine, Atlanta, Georgia
| | - Tobias Todsen
- Department of Otorhinolaryngology, Head and Neck Surgery, University of Copenhagen, Copenhagen, Denmark
| | - Khaled Twier
- Department of Otohinolaryngology, University of Cape Town, Cape Town, South Africa
| | - Johannes J Fagan
- Department of Otohinolaryngology, University of Cape Town, Cape Town, South Africa
| |
Collapse
|